DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Penson RT, Valencia RV, Cibula D. et al.
Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial.
J Clin Oncol 2020;
38: 1164-1174
DOI: 10.1200/JCO.19.02745.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.